New York, New York (PRWEB) August 03, 2014
Transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) alleging serious complications due to pelvic mesh products manufactured by Ethicon Inc. continue to mount in state and federal litigations, Bernstein Liebhard LLP reports. According to a Case List issued on July 28th, at least 6,870 such claims have been filed in a multicounty litigation underway in New Jersey’s Atlantic County Superior Court. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10)
“Our Firm is representing hundreds of women in vaginal mesh lawsuits that are pending in both state and federal proceedings, and we continue to receive inquiries from others who were allegedly harmed by surgical mesh used to treat pelvic organ prolapse and stress urinary incontinence. We are not surprised that the New Jersey Ethicon litigation continues to grow,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to investigate transvaginal mesh lawsuits on behalf of women who suffered serious injuries, allegedly due to products marketed by Ethicon and other manufacturers.
Ethicon Vaginal Mesh Litigation
According to court documents, the transvaginal mesh litigation has been building since October 2008, when the U.S. Food & Drug Administration (FDA) alerted the public to the serious risks associated with the devices. In July 2011, the agency issued a second alert after it received thousands of additional reports of injuries associated with transvaginal mesh. This past April, the FDA proposed reclassifying vaginal mesh used to treat pelvic organ prolapse as high-risk medical devices, which would subject the devices to greater regulatory scrutiny.
According to court filings, all of the claims pending in the New Jersey litigation allege Ethicon’s pelvic mesh products caused recipients to suffer serious vaginal mesh complications, including chronic pain, mesh erosion, and organ damage. Plaintiffs further allege that the devices were defectively designed and inadequately tested, and that Ethicon did not provide doctors and patients with appropriate warnings regarding their risks.
Jeffrey S. Grand, a partner with Bernstein Liebhard LLP, is serving as Co-Liaison Counsel in the New Jersey Ethicon litigation. He was also a member of the Plaintiff’s trial team for the first trial in that proceeding, which ended in March 2013 with a jury awarding $11 million in compensatory and punitive damages to a woman who suffered vaginal mesh complications related to the Ethicon Gynecare Prolift device. (Gross v. Gynecare Inc., Atl-L-6966-10)
Mr. Grand has also been appointed Co-Liaison Counsel in a second proceeding in Atlantic County that involves transvaginal mesh lawsuits filed against C.R. Bard, Inc. ( In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Court records indicate Ethicon is also named in more than 19,000 transvaginal mesh claims that are currently pending in a multidistrict litigation underway in U.S. District Court, Southern District of West Virginia. Mr. Grand is serving on the Plaintiffs’ Steering Committee for that proceeding. (In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327)
Mr. Grand is also a member of the Plaintiffs’ Steering Committee for several other consolidated litigations underway in the Southern District of West Virginia, including those involving: American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187).
Alleged victims of serious vaginal mesh complications may be able to pursue their own legal claim against the manufacturer of their device. To learn more about the ongoing transvaginal mesh litigation, please visit Bernstein Liebhard LLP's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP